Award
Delivery Order #SPE2DR26FZ1T9
AmerisourceBergen Delivers Letrozole Tablets Under Supplemental Delivery Order
Buyer
Defense Logistics Agency
Award Amount
$999.78
Ceiling
$999.78
Awarded
March 11, 2026
Period of Performance
Mar 11, 2026 – Mar 12, 2026
Identifier
SPE2DR26FZ1T9
NAICS
424210
This award represents a definitive delivery order contract under an existing indefinite delivery vehicle (IDV) with AmerisourceBergen Drug Corp, a leading pharmaceutical distributor. The contract procures Letrozole 2.5 mg tablets, a critical pharmaceutical product used in healthcare treatments, enhancing the government's ability to provide essential medications efficiently. The delivery order supports a specific short-term requirement within the broader IDV contract focused on pharmaceutical supply services to government health programs. This contract was likely competitively sourced under the umbrella IDV, ensuring quality and cost-effectiveness. The performance period is a concise two-day window in early 2026, indicating an expedited fulfillment of the pharmaceutical delivery. This award builds on the long-term strategic partnership established by AmerisourceBergen's prior IDV contract, which aims to strengthen government healthcare supply chains over a decade-plus timeframe.
Description
4571118824!LETROZOLE 2.5 MG TABLET 90S